Literature DB >> 16579784

Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).

Susan N Ettinger1, Timothy J Scase, Karen T Oberthaler, Diane M Craft, Josephine A McKnight, Nicole F Leibman, Sarah C Charney, Philip J Bergman.   

Abstract

OBJECTIVE: To determine whether argyrophilic nucleolar organizing regions (AgNORs), Ki-67, and proliferating cell nuclear antigen (PCNA) scores were associated with histologic grade and survival in dogs with soft tissue sarcomas (STSs).
DESIGN: Retrospective study. ANIMALS: 60 dogs with STSs. PROCEDURE: Medical records were examined and histologic specimens were reviewed. Tissue specimens obtained from archival materials were used to prepare sections for histologic staining for AgNOR and immunohistochemical staining for Ki-67 and PCNA labeling. Follow-up monitoring was obtained by reevaluation or telephone conversations with referring veterinarians or owners.
RESULTS: 27 (45%) STSs were grade 1, 23 (38%) were grade 2, and 10 (17%) were grade 3. The mean and median AgNOR, Ki-67, and PCNA scores were determined, and significant positive associations among AgNOR and Ki-67 scores with histologic grade and mitotic score were detected. Fifty-four dogs had adequate follow-up examinations and were included in survival analysis and evaluation of prognostic factors. Overall median survival time was > 1,306 days. Twelve of 54 (22%) dogs died of tumor-related causes. Metastatic disease developed in 8 of 54 (15%) dogs. Results of univariate analysis indicated that increased mitotic score, increased AgNOR score, increased Ki-67 score, incomplete surgical margins, noncurative intent surgery, Ki-67 score greater than the median Ki-67 score, and AgNOR score greater than the median AgNOR score were prognostic factors for decreased survival time. Results of multivariate analysis indicated that increased AgNOR score was the only prognostic factor for decreased survival time. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that AgNORs and possibly Ki-67 should be routinely evaluated with histologic grading for STSs in dogs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16579784     DOI: 10.2460/javma.228.7.1053

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  8 in total

1.  Feasibility of using gene expression analysis to study canine soft tissue sarcomas.

Authors:  Jennifer A Mahoney; Julie C Fisher; Stacey A Snyder; Marlene L Hauck
Journal:  Mamm Genome       Date:  2010-11-13       Impact factor: 2.957

Review 2.  DCE-MRI: a review and applications in veterinary oncology.

Authors:  M Keara Boss; N Muradyan; D E Thrall
Journal:  Vet Comp Oncol       Date:  2011-12-08       Impact factor: 2.613

3.  Endosialin (CD248) Expression in Fibromas and Soft-tissue Fibrosarcomas in Dogs.

Authors:  Magdalena Marzec; Małgorzata Kandefer-Gola; Izabela Janus; Joanna Bubak; Marcin Nowak
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.406

4.  Primary leiomyosarcoma of the jugular vein in a dog.

Authors:  Alessio Pierini; Filippo Cinti; Diana Binanti; Guido Pisani
Journal:  Open Vet J       Date:  2017-03-11

5.  Hepatic fibrosarcoma incarcerated in a peritoneopericardial diaphragmatic hernia in a cat.

Authors:  Michael Linton; Lydia Tong; Adrian Simon; Eugene Buffa; Ross McGregor; Julien Labruyére; Darren Foster
Journal:  JFMS Open Rep       Date:  2016-03-17

6.  Mediastinal Fibrosarcoma in a Dog-Case Report.

Authors:  Alysha M McGrath; Sarah A Salyer; Amanda Seelmann; Alycen P Lundberg; Melissa R Leonard; Joshua N Lorbach; Sarah Lumbrezer-Johnson; Eric T Hostnik; Giovanni Tremolada; Janis Lapsley; Laura E Selmic
Journal:  Front Vet Sci       Date:  2022-02-09

7.  Canine Soft Tissue Sarcomas: Can Being a Dog's Best Friend Help a Child?

Authors:  Bernard Séguin
Journal:  Front Oncol       Date:  2017-11-23       Impact factor: 6.244

Review 8.  Cytogenomics of Feline Cancers: Advances and Opportunities.

Authors:  Rachael Thomas
Journal:  Vet Sci       Date:  2015-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.